SELLAS Life Sciences Group Inc.

SLS | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.84

+$0.47 (+4.13%)

Sep 22, 2026, 1:16 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1M	1M	1M	2.9M	7.6M	9.5M	9.5M	7.6M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	100K	100K	100K	200K	200K	200K	200K	100K
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	900K	900K	900K	2.7M	7.4M	9.3M	9.3M	7.5M
Operating Income	-35.22M	-31.46M	-28.27M	-26.94M	-27.18M	-27.93M	-31.51M	-32.77M	-34.8M	-36.23M	-37.87M	-39.14M	-36.92M	-36.5M	-31.95M	-28.42M	-28.25M	-24.08M	-19.59M	-17.83M	-15.35M	-15.16M
Interest Income	2.76M	2.01M	1.41M	995K	924K	803K	632K	492K	365K	422K	525K	642K	659K	497K	317K	159K	50K	6K	6K	7K	5K	4K
Pretax Income	-32.46M	-29.46M	-26.86M	-25.94M	-26.26M	-27.13M	-30.88M	-32.28M	-34.44M	-35.81M	-37.34M	-38.33M	-36.08M	-35.65M	-41.3M	-39.02M	-39.08M	-35.28M	-20.94M	-17.83M	-15.22M	-15.03M
Net Income	-32.46M	-29.46M	-26.86M	-25.94M	-26.26M	-27.13M	-30.88M	-32.28M	-34.44M	-35.81M	-37.34M	-38.33M	-36.08M	-35.65M	-41.3M	-38.78M	-38.84M	-35.04M	-20.7M	-17.82M	-15.21M	-15.02M
Selling & General & Admin	14.87M	13.52M	12.25M	11.21M	11.31M	10.74M	12.42M	13.02M	13.6M	14.29M	13.86M	14.38M	13.7M	13.67M	12.58M	11.51M	11.08M	10.78M	11.32M	12.08M	11.77M	10.96M
Research & Development	20.35M	17.95M	16.02M	15.73M	15.88M	17.19M	19.1M	19.76M	21.21M	21.94M	24.01M	24.76M	23.23M	22.83M	20.27M	17.82M	18.07M	16M	15.67M	15.05M	12.88M	11.7M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	35.22M	31.46M	28.27M	26.94M	27.18M	27.93M	31.51M	32.77M	34.8M	36.23M	37.87M	39.14M	36.92M	36.5M	32.85M	29.32M	29.15M	26.78M	26.99M	27.13M	24.65M	22.66M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	35.22M	31.46M	28.27M	26.94M	27.18M	27.93M	31.51M	32.77M	34.8M	36.23M	37.87M	39.14M	36.92M	36.5M	32.95M	29.42M	29.25M	26.98M	27.19M	27.33M	24.85M	22.76M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-237K	-237K	-237K	-237K	-17K	-17K	-17K
Shares Outstanding (Basic)	189.18M	172.48M	153.1M	108.4M	94.3M	87.76M	73.99M	68.25M	57.46M	44.81M	30.8M	28.36M	28.35M	23.55M	20.79M	20.56M	20.29M	15.9M	15.89M	15.87M	15.27M	14.88M
Shares Outstanding (Diluted)	189.18M	172.48M	153.1M	108.4M	98.56M	87.76M	73.99M	68.25M	57.63M	44.81M	30.8M	28.36M	28.35M	23.55M	20.79M	20.56M	20.29M	15.9M	15.89M	15.87M	15.27M	14.88M
EPS (Basic)	-0.21	-0.23	-0.25	-0.29	-0.32	-0.39	-0.53	-0.70	-0.93	-1.11	-1.37	-1.55	-1.56	-1.66	-2.24	-2.22	-2.33	-2.22	-1.33	-1.27	-1.35	-1.71
EPS (Diluted)	-0.21	-0.23	-0.25	-0.29	-0.33	-0.39	-0.53	-0.70	-0.93	-1.11	-1.37	-1.55	-1.56	-1.66	-2.24	-2.22	-2.33	-2.22	-1.33	-1.27	-1.35	-1.71
EBITDA	-25.38M	-22.37M	-19.78M	-18.86M	-26.26M	-27.13M	-30.88M	-32.28M	-34.44M	-35.65M	-37.18M	-38.04M	-35.59M	-35.24M	-40.84M	-37.41M	-37.68M	-33.96M	-18.66M	-13.1M	-10.5M	-10.16M
EBIT	-32.46M	-29.46M	-26.86M	-25.94M	-26.26M	-27.13M	-30.88M	-32.28M	-34.44M	-35.81M	-37.34M	-38.33M	-36.08M	-35.65M	-41.3M	-39.01M	-39.08M	-35.28M	-20.78M	-18.1M	-15.51M	-15.16M
Depreciation & Amortization	7.08M	7.08M	7.08M	7.08M	n/a	n/a	n/a	n/a	n/a	158K	158K	281K	488K	412K	457K	1.61M	1.4M	1.32M	2.12M	5.01M	5.01M	5.01M